Discovery, development and application of drugs targeting BCL-2 pro-survival proteins in cancer

被引：6
|
作者：
Lee, Erinna F. [1 ,2 ,3 ]
Fairlie, W. Douglas [1 ,2 ,3 ]
机构：
[1] La Trobe Univ, La Trobe Inst Mol Sci, Melbourne, Vic 3086, Australia
[2] Olivia Newton John Canc Res Inst, Cell Death & Survival Lab, Heidelberg, Vic 3084, Australia
[3] La Trobe Univ, Sch Canc Med, Bundoora, Vic 3086, Australia
来源：
BIOCHEMICAL SOCIETY TRANSACTIONS | 2021年 / 49卷 / 05期
基金：
英国医学研究理事会;
关键词：
CHRONIC LYMPHOCYTIC-LEUKEMIA; SELECTIVE SMALL-MOLECULE; STRUCTURE-GUIDED DESIGN; ANTI-APOPTOTIC MCL-1; BH3 MIMETIC ABT-737; X-L; CYTOCHROME-C; IN-VIVO; HIGH-AFFINITY; CELL-DEATH;
D O I：
10.1042/BST20210749
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
The discovery of a new class of small molecule compounds that target the BCL-2 family of anti-apoptotic proteins is one of the great success stories of basic science leading to translational outcomes in the last 30 years. The eponymous BCL-2 protein was identified over 30 years ago due to its association with cancer. However, it was the unveiling of the biochemistry and structural biology behind it and its close relatives' mechanism(s)-ofaction that provided the inspiration for what are now known as 'BH3-mimetics', the first clinically approved drugs designed to specifically inhibit protein-protein interactions. Herein, we chart the history of how these drugs were discovered, their evolution and application in cancer treatment.
引用
收藏
页码：2381 / 2395
页数：15
相关论文
共 50 条
  • [1] Targeting the Pro-survival Protein BCL-2 to Prevent Breast Cancer
    Young, Adelaide
    Bu, Wen
    Jiang, Weiyu
    Ku, Amy
    Kapali, Jyoti
    Dhamne, Sagar
    Qin, Lan
    Hilsenbeck, Susan G.
    Du, Yi-Chieh Nancy
    Li, Yi
    CANCER PREVENTION RESEARCH, 2022, 15 (01) : 3 - 10
  • [2] Targeting lymphoid malignancies with small molecule inhibitors of pro-survival Bcl-2 proteins.
    Roberts, AW
    Wei, A
    van Delft, MF
    Mason, KD
    Adams, JM
    Huang, DCS
    BLOOD, 2005, 106 (11) : 428A - 428A
  • [3] Co-Operativity between MYC and BCL-2 Pro-Survival Proteins in Cancer
    Fairlie, Walter Douglas
    Lee, Erinna F.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (06) : 1 - 28
  • [4] Role and Regulation of Pro-survival BCL-2 Proteins in Multiple Myeloma
    Slomp, Anne
    Peperzak, Victor
    FRONTIERS IN ONCOLOGY, 2018, 8
  • [5] Targeting Pro-survival Bcl-2 Proteins in Haematological Malignancies Driven by Activated Mutant JAK2
    Waibel, M.
    Solomon, V. S.
    Ralli, R.
    Vidacs, E.
    Kim, S. K.
    Banks, K. M.
    Johnstone, R. W.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S640 - S640
  • [6] Bim and the pro-survival bcl-2 proteins - Opposites attract, ERK repels
    Ewings, Katherine E.
    Wiggins, Ceri M.
    Cook, Simon J.
    CELL CYCLE, 2007, 6 (18) : 2236 - 2240
  • [7] Targeting pro-survival BCL-2 family members increases radiation sensitivity in breast cancer cells
    Wu, Hao
    Schiff, Devora S.
    Goyal, Sharad
    Neboori, Hanmanth J. R.
    Haffty, Bruce G.
    CANCER RESEARCH, 2011, 71
  • [8] The role of Bcl-2 and its pro-survival relatives in tumourigenesis and cancer therapy
    P N Kelly
    A Strasser
    Cell Death & Differentiation, 2011, 18 : 1414 - 1424
  • [9] Deciphering the BH3 code for the neutralization of pro-survival Bcl-2 proteins
    Das, K. K.
    Saez, A. J. Garcia
    EUROPEAN BIOPHYSICS JOURNAL WITH BIOPHYSICS LETTERS, 2015, 44 : S125 - S125
  • [10] The role of Bcl-2 and its pro-survival relatives in tumourigenesis and cancer therapy
    Kelly, P. N.
    Strasser, A.
    CELL DEATH AND DIFFERENTIATION, 2011, 18 (09): : 1414 - 1424
12345